Publication: 2081

Predicting response and survival in chemotherapy-treated triple-negative breast cancer
      QxMD      Google Scholar   
Citation:
Br J Cancer vol 111 (8) 1532-1541
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
This work was presented, in part, as an oral communication at the ASCO 2012 annual meeting (Abstract #10500)
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
4
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171 , U01 CA114722-01, P50-CA58223-09A1, U10 CA033601, R01 CA138255, U10 CA180821, P30 CA016086, U01 CA114722, P50 CA058223, R01-CA138255, U10-CA33601, U10 CA180882, U24 CA196171, U10 CA180838  
Corr. Author:
 
Authors:
                                                                             
Networks:
 
Study
CALGB-159905
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-9741
Phases:
N/A, 3
Keywords:
breast cancer, genomics, subtypes, intrinsic, basal like, chemotherapy, neoadjuvant